Health Policy Analysis
Health policy decisions affect populations, budgets, and markets in ways that are rarely straightforward to predict or measure. Impacts emerge over time, vary across population groups, and interact with system constraints that simple models don't capture.
Zeumed provides economic analysis to support these decisions — for governments and payers, for patient organisations and advocacy groups, and for life science companies operating in markets shaped by policy.
WHAT WE DO
Health Policy Analysis Work
Assessing expected impacts before implementation
Analysing how proposed policies, investments, or service changes are likely to affect demand, costs, outcomes, and system performance — taking account of population characteristics, utilisation patterns, and behavioural response. This includes simulation modelling and scenario analysis to test assumptions and quantify impacts under different conditions.
Real World Evidence
Using electronic health records, claims data, and administrative datasets to answer policy questions that trial-based evidence cannot address at population scale. Zeumed commonly uses EHR data to identify clinical patterns, assess variation in practice and outcomes across providers and populations, and evaluate how policy and payment decisions play out in real systems.
Evaluating observed impacts after implementation
Using real-world data to assess how systems actually respond once a decision is in place, and whether observed effects align with expectations. Drawing on administrative and observational data — claims, electronic health records, registries, and programme data — to test assumptions, interpret results, and support credible communication of findings.
Wider Ecosystem Impact
Assessing the broader economic and health value of health system investments — including the impact of biotech and clinical trial ecosystems on population health outcomes, health system capacity, and wider economic performance.
OUR WORK
Selected Engagements
PAYER · PREVENTATIVE HEALTH POLICY · SIMULATION & SCENARIO ANALYSES
Impact assessment for preventative health policies
Zeumed conducted economic impact assessments for a series of preventative health policies — including product reformulation requirements and policies targeting unhealthy consumption patterns. The work used simulation modelling and scenario analysis to estimate population-level health impacts, fiscal consequences, and distributional effects across income and demographic groups, providing decision-makers with a quantified basis for policy comparison and selection.
ECOSSYTEM ASSESSMENT· BIOTECH AND LIFE SCIENCES
Economic and health impact assessment of a biotech ecosystem
Zeumed assessed the economic and population health value generated by a biotech and life sciences ecosystem — quantifying contributions to health outcomes, health system capacity, and wider economic performance including employment, productivity, and innovation spillovers. The analysis provided a basis for government investment decisions and policy design to strengthen the ecosystem over time.
ECOSSYTEM ASSESSMENT· CLINICAL TRIALS
Assessment of the health and economic value of a clinical trial ecosystem
Zeumed is currently assessing the health and economic value of a clinical trial ecosystem in a Western European market — examining the direct benefits to patients participating in trials, the contribution to health system capability and capacity, and the wider economic returns to the host economy. The work draws on real-world data and health-adjusted life expectancy analysis to quantify value across multiple dimensions.
CONNECTED WORK
Low Value Care
Identifying and addressing low value care — interventions that generate cost without commensurate benefit — is the other side of the value-based healthcare challenge. Zeumed has developed a dedicated methodology and analytical framework for low value care identification and payment reform.
Get in Touch
We welcome enquiries from policymakers, payers, patient organisations, and life science companies working on health policy analysis and impact assessment.